Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation.
Imamura T, Okamura Y, Ohshima K, Uesaka K, Sugiura T, Ito T, Yamamoto Y, Ashida R, Ohgi K, Otsuka S, Ohnami S, Nagashima T, Hatakeyama K, Kakuda Y, Sugino T, Urakami K, Akiyama Y, Yamaguchi K.
Imamura T, et al. Among authors: okamura y.
Cancer Med. 2022 Apr;11(8):1769-1786. doi: 10.1002/cam4.4571. Epub 2022 Feb 17.
Cancer Med. 2022.
PMID: 35174643
Free PMC article.